首页> 美国卫生研究院文献>Antioxidants >Suicidal Erythrocyte Death in Metabolic Syndrome
【2h】

Suicidal Erythrocyte Death in Metabolic Syndrome

机译:代谢综合征的自杀红细胞死亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Eryptosis is a coordinated, programmed cell death culminating with the disposal of cells without disruption of the cell membrane and the release of endocellular oxidative and pro-inflammatory milieu. While providing a convenient form of death for erythrocytes, dysregulated eryptosis may result in a series of detrimental and harmful pathological consequences highly related to the endothelial dysfunction (ED). Metabolic syndrome (MetS) is described as a cluster of cardiometabolic factors (hyperglycemia, dyslipidemia, hypertension and obesity) that increases the risk of cardiovascular complications such as those related to diabetes and atherosclerosis. In the light of the crucial role exerted by the eryptotic process in the ED, the focus of the present review is to report and discuss the involvement of eryptosis within MetS, where vascular complications are utterly relevant. Current knowledge on the mechanisms leading to eryptosis in MetS-related conditions (hyperglycemia, dyslipidemia, hypertension and obesity) will be analyzed. Moreover, clinical evidence supporting or proposing a role for eryptosis in the ED, associated to MetS cardiovascular complications, will be discussed.
机译:红绿腺化是一种协调的,编程的细胞死亡,最终处理细胞,而不会破坏细胞膜和内肠胃外氧化和促炎米利的释放。在为红细胞提供方便的死亡形式的同时,令人遗憾的红绿腺化可能导致与内皮功能障碍(ED)高度相关的一系列有害和有害的病理后果。代谢综合征(METS)被描述为一群心脏素因子(高血糖,血脂血症,高血压和肥胖),其增加了心血管并发症,例如与糖尿病和动脉粥样硬化相关的风险。鉴于ED中红细胞过程所施加的至关重要的作用,本综述的重点是报告并讨论红绿腺化案中的嗜血症病,其中血管并发症完全相关。将分析关于导致Mets-相关病症(高血糖,血脂症,高血压和肥胖)的鸡红霉病机制的知识。此外,将讨论临床证据或提出与培养心血管并发症相关的ED射刺症作用的临床证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号